Biosimilar Utilization and Inventory Management

EP: 1.Comparing Biologics and Biosimilars

Now Viewing

EP: 2.Biosimilar Utilization and Inventory Management

EP: 3.Operationalizing Biosimilars in Specialty Pharmacies

EP: 4.Advice for States that Require Prior Prescriber Approval for Substitution

EP: 5.Key Factors to Consider when Switching to Biosimilars

EP: 6.Pharmacy and Provider Collaboration

EP: 7.Biosimilar Copay Programs

Video content above is prompted by the following:

• How has the introduction of biosimilars affected the biologic landscape at specialty pharmacies, including the disease states treated and trends in utilization?
• What strategies, including the “just in time” inventory model, can specialty pharmacies employ to effectively manage their high-cost biologic and biosimilar inventory given the challenges of limited shelf space?